nitrates has been researched along with Esophageal and Gastric Varices in 20 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
Esophageal and Gastric Varices: Dilated blood vessels in the ESOPHAGUS or GASTRIC FUNDUS that shunt blood from the portal circulation (PORTAL SYSTEM) to the systemic venous circulation. Often they are observed in individuals with portal hypertension (HYPERTENSION, PORTAL).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Based on low-certainty evidence, beta-blockers, variceal band ligation, sclerotherapy, and beta-blockers plus nitrates may decrease mortality compared to no intervention in people with high-risk oesophageal varices in people with cirrhosis and no previous history of bleeding." | 5.12 | Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis. ( Arunan, S; Begum, T; Benmassaoud, A; Best, LM; Cooper, NJ; Csenar, M; Davidson, BR; Freeman, SC; Gurusamy, KS; Iogna Prat, L; Milne, EJ; Pavlov, CS; Plaz Torres, MC; Roberts, D; Roccarina, D; Sutton, AJ; Tapp, M; Tsochatzis, E; Williams, NR, 2021) |
| "About 15% to 20% of oesophageal varices bleed in about one to three years of diagnosis." | 2.72 | Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis. ( Arunan, S; Begum, T; Benmassaoud, A; Best, LM; Cooper, NJ; Csenar, M; Davidson, BR; Freeman, SC; Fritche, D; Gurusamy, KS; Iogna Prat, L; Milne, EJ; Pavlov, CS; Plaz Torres, MC; Roberts, D; Roccarina, D; Sutton, AJ; Tapp, M; Tsochatzis, E; Williams, NR, 2021) |
| "About 15% to 20% of oesophageal varices bleed within about one to three years after diagnosis." | 2.72 | Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis. ( Arunan, S; Begum, T; Best, LM; Cooper, NJ; Csenar, M; Davidson, BR; Freeman, SC; Gurusamy, KS; Milne, EJ; Pavlov, CS; Roberts, D; Sutton, AJ; Tapp, M; Tsochatzis, E; Walshaw, D; Williams, NR, 2021) |
| "Recent advances in the pharmacologic treatment of portal hypertension have mainly focused on modifying an increased intrahepatic resistance through nitric oxide and/or modulation of vasoactive substances." | 2.61 | Pharmacologic Management of Portal Hypertension. ( Bunchorntavakul, C; Reddy, KR, 2019) |
| "In conclusion, chronic administration of organic nitrates, allowing for a nitrate-free interval each day, to cirrhotic patients reduces portal pressure with a variable, dose-dependent effect on azygos blood flow." | 2.39 | Organic nitrates in portal hypertension. ( Hayes, PC; Jones, AL, 1994) |
| "The prevalence of large esophageal varices was 20%." | 1.30 | Predictors of large esophageal varices in patients with cirrhosis. ( Boyer, TD; Carey, M; Chalasani, N; Imperiale, TF; Ismail, A; Kwo, PY; Madichetty, H; Sood, G; Wilcox, CM, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 4 (20.00) | 18.2507 |
| 2000's | 9 (45.00) | 29.6817 |
| 2010's | 3 (15.00) | 24.3611 |
| 2020's | 3 (15.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bunchorntavakul, C | 1 |
| Reddy, KR | 1 |
| Plaz Torres, MC | 2 |
| Best, LM | 3 |
| Freeman, SC | 3 |
| Roberts, D | 3 |
| Cooper, NJ | 3 |
| Sutton, AJ | 3 |
| Roccarina, D | 2 |
| Benmassaoud, A | 2 |
| Iogna Prat, L | 2 |
| Williams, NR | 3 |
| Csenar, M | 3 |
| Fritche, D | 1 |
| Begum, T | 3 |
| Arunan, S | 3 |
| Tapp, M | 3 |
| Milne, EJ | 3 |
| Pavlov, CS | 3 |
| Davidson, BR | 3 |
| Tsochatzis, E | 3 |
| Gurusamy, KS | 3 |
| Walshaw, D | 1 |
| Mustafa, MZ | 1 |
| Stanley, A | 1 |
| Augustin, S | 1 |
| González, A | 1 |
| Badia, L | 1 |
| Millán, L | 1 |
| Gelabert, A | 1 |
| Romero, A | 1 |
| Segarra, A | 1 |
| Martell, M | 1 |
| Esteban, R | 1 |
| Guardia, J | 1 |
| Genescà, J | 1 |
| Groszmann, RJ | 1 |
| Garcia-Tsao, G | 1 |
| Arkenau, HT | 1 |
| Stichtenoth, DO | 1 |
| Frölich, JC | 1 |
| Manns, MP | 1 |
| Böker, KH | 1 |
| Imperiale, TF | 2 |
| Chalasani, N | 2 |
| Klein, RW | 1 |
| Targownik, LE | 1 |
| Spiegel, BM | 1 |
| Dulai, GS | 1 |
| Karsan, HA | 1 |
| Gralnek, IM | 1 |
| Rockey, DC | 1 |
| Jones, AL | 1 |
| Hayes, PC | 1 |
| El-Newihi, HM | 1 |
| Kanji, VK | 1 |
| Mihas, AA | 1 |
| Lebrec, D | 1 |
| Ismail, A | 1 |
| Sood, G | 1 |
| Carey, M | 1 |
| Wilcox, CM | 1 |
| Madichetty, H | 1 |
| Kwo, PY | 1 |
| Boyer, TD | 1 |
| Sanyal, AJ | 1 |
| Angelico, M | 1 |
| Lionetti, R | 1 |
| Lowe, RC | 1 |
| Grace, ND | 1 |
| Vogt, W | 1 |
| Fleig, WE | 1 |
13 reviews available for nitrates and Esophageal and Gastric Varices
| Article | Year |
|---|---|
Pharmacologic Management of Portal Hypertension.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Anticoagulants; Antihypertensi | 2019 |
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.
Topics: Adrenergic beta-2 Receptor Antagonists; Adult; Bias; Esophageal and Gastric Varices; Gastrointestina | 2021 |
Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis.
Topics: Adrenergic beta-Antagonists; Bias; Combined Modality Therapy; Drug Therapy, Combination; Esophageal | 2021 |
Treatment for bleeding oesophageal varices in people with decompensated liver cirrhosis: a network meta-analysis.
Topics: Adult; Bayes Theorem; Bias; Combined Modality Therapy; Esophageal and Gastric Varices; Gastrointesti | 2021 |
Variceal rebleeding: use of drug therapy and endoscopic band ligation.
Topics: Adrenergic beta-Antagonists; Combined Modality Therapy; Drug Therapy, Combination; Endoscopy, Gastro | 2014 |
Endoscopic variceal banding vs. pharmacological therapy for the prevention of recurrent variceal hemorrhage: what makes the difference?
Topics: Adrenergic beta-Antagonists; Endoscopy; Esophageal and Gastric Varices; Humans; Nitrates; Secondary | 2002 |
Pharmacologic therapy for gastrointestinal bleeding due to portal hypertension and esophageal varices.
Topics: Adrenergic beta-Antagonists; Algorithms; Antihypertensive Agents; Cardiovascular Agents; Esophageal | 2006 |
Organic nitrates in portal hypertension.
Topics: Animals; Collateral Circulation; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans | 1994 |
Review: pharmacotherapeutic agents in the treatment of portal hypertension.
Topics: Adrenergic beta-Antagonists; Esophageal and Gastric Varices; Forecasting; Gastrointestinal Hemorrhag | 1997 |
Long-acting nitrates in portal hypertension: to be or not to be?
Topics: Adrenergic beta-Antagonists; Delayed-Action Preparations; Esophageal and Gastric Varices; Female; Ga | 2001 |
Primary prophylaxis of variceal hemorrhage.
Topics: Adrenergic beta-Antagonists; Endoscopy; Esophageal and Gastric Varices; Hemorrhage; Humans; Hyperten | 2001 |
[The patient with hematemesis. What to do?].
Topics: Adrenergic beta-Antagonists; Aged; Drug Therapy, Combination; Electrocoagulation; Emergencies; Endos | 2002 |
Pharmacological methods for the prevention of first and recurrent bleeding from esophagogastric varices.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Esophageal and Gastric Varices; Gastrointesti | 1988 |
7 other studies available for nitrates and Esophageal and Gastric Varices
| Article | Year |
|---|---|
Long-term follow-up of hemodynamic responders to pharmacological therapy after variceal bleeding.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Esophageal and Gastric Varices; Female; Follow-Up Studies; | 2012 |
Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.
Topics: Ascites; Data Interpretation, Statistical; Esophageal and Gastric Varices; Hemodynamics; Hepatitis, | 2002 |
Measuring the hemodynamic response to primary pharmacoprophylaxis of variceal bleeding: a cost-effectiveness analysis.
Topics: Adrenergic beta-Antagonists; Cost-Benefit Analysis; Decision Trees; Esophageal and Gastric Varices; | 2003 |
The cost-effectiveness of hepatic venous pressure gradient monitoring in the prevention of recurrent variceal hemorrhage.
Topics: Adrenergic beta-Antagonists; Blood Pressure Determination; Cost-Benefit Analysis; Endoscopy, Digesti | 2004 |
Activity of gastric mucosal nitric oxide synthase in portal hypertensive gastropathy.
Topics: Adult; Aged; Esophageal and Gastric Varices; Gastric Mucosa; Humans; Hypertension, Portal; Liver Cir | 1996 |
Predictors of large esophageal varices in patients with cirrhosis.
Topics: Adrenergic beta-Antagonists; Cohort Studies; Confidence Intervals; Cost-Benefit Analysis; Costs and | 1999 |
Hepatic venous pressure gradient: to measure or not to measure, that is the question.
Topics: Adrenergic beta-Antagonists; Drug Synergism; Esophageal and Gastric Varices; Hemorrhage; Hepatic Vei | 2000 |